Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.
Microbial Identification with ID Cards
The identification process begins with the preparation of a standardized suspension from isolated, pure microbial colonies. This suspension is inoculated into specialized ID cards, each containing multiple wells with predefined biochemical substrates. Different ID cards are available for Gram-negative bacteria, Gram-positive bacteria, and yeasts, allowing organism-specific testing.
As the microorganism metabolizes the substrates, changes in color or turbidity occur in the wells. The instrument continuously monitors these changes and generates a unique biochemical activity profile. This profile is then algorithmically compared with an extensive internal database to enable accurate and reproducible species-level identification.
Antibiotic Susceptibility Testing
In parallel, AST cards assess the growth response of the microorganism to a range of antibiotics at predefined concentrations. Each well in the AST card contains a specific antibiotic, and the analyzer tracks microbial growth over time. Absence or marked reduction of growth indicates susceptibility, while visible growth reflects resistance.
The system calculates the minimum inhibitory concentration (MIC)—the lowest concentration of an antibiotic that prevents visible microbial growth. These MIC values are interpreted according to internationally recognized clinical guidelines, such as CLSI or EUCAST, to categorize pathogens as susceptible, intermediate, or resistant.
Clinical Utility
The integration of automated ID and AST through the Vitek 2 system shortens diagnostic timelines compared to manual methods, enabling clinicians to initiate targeted antimicrobial therapy earlier. This rapid turnaround improves patient outcomes, supports antimicrobial stewardship by limiting inappropriate antibiotic use, and helps control the spread of resistant organisms. Rigorous internal quality control procedures further enhance accuracy and reliability, reinforcing the clinical value of this technology.
Automated diagnostic analyzers, like the Vitek 2, rapidly identify pathogens and test antibiotic susceptibility.
Suspensions of pure microbial colonies are loaded into appropriate identification, or ID cards, and antibiotic susceptibility testing, or AST cards.
The ID cards contain multiple wells with various substrates that react with microbial enzymes.
Microbial metabolic activities cause changes in the color or turbidity over time, which are detected by the instrument.
The resulting biochemical profile is then matched with a database to identify the microbial species.
Simultaneously, the AST cards contain wells with increasing concentrations of different antibiotics to monitor bacterial growth by turbidity.
By observing growth, the system determines the susceptibility and the minimum inhibitory concentration of a particular antibiotic.
Results are compared to clinical standards, which classify bacteria as susceptible, intermediate, or resistant.
Finally, the system applies automated expert rules to validate results before reporting.
繁體中文
